1-4 of 4
Jeff S. Aycock, BA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Rates of Minimal Residual Disease-Negative (MRD−) Complete Responses (CR) in Adult and Pediatric and Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) Treated With KTE-C19 (Anti-CD19 Chimeric Antigen Receptor [CAR] T Cells): Preliminary Results of the ZUMA-3 and ZUMA-4 Trials

Bijal Shah, MD, Van Huynh, MD, Leonard S. Sender, MD, Daniel W. Lee, III, MD, Januario E. Castro, MD, William G. Wierda, MD PhD, Andrew C. Dietz, MD MSCR, Gary J. Schiller, MD, Marie José Kersten, MD PhD, Rupert Handgretinger, MD PhD, Patrick Brown, MD, Lia Gore, MD, Nicola Gökbuget, MD, Joseph Rosenthal, MD MS, Marianna Sabatino, MD, Adrian Bot, MD PhD, John M. Rossi, MS, Yizhou Jiang, PhD, Lynn Navale, MS, Shanna Stout, BS, Jeff S. Aycock, BA, Jeff Wiezorek, MD MS, Rajul Jain, MD, Alan S. Wayne, MD
Journal: Blood
Blood (2016) 128 (22): 2803.
https://doi.org/10.1182/blood.V128.22.2803.2803
Published: 2016
Journal Articles

A Phase 2 Multicenter Trial of KTE-C19 (anti-CD19 CAR T Cells) in Patients With Chemorefractory Primary Mediastinal B-Cell Lymphoma (PMBCL) and Transformed Follicular Lymphoma (TFL): Interim Results From ZUMA-1

Sattva S. Neelapu, MD, Frederick L. Locke, MD, Nancy L Bartlett, MD, Tanya Siddiqi, MD, Caron A. Jacobson, MD, Jason R. Westin, MD, Julio C. Chavez, MD, Armin Ghobadi, MD, Alex F Herrera, MD, Ann S. LaCasce, MD, Adrian Bot, MD PhD, John M. Rossi, MS, Yizhou Jiang, PhD, Jeff S. Aycock, BA, Meg Elias, RN,BSN, Jeff Wiezorek, MD MS, William Y. Go, MD PhD
Journal: Blood
Blood (2016) 128 (22): 998.
https://doi.org/10.1182/blood.V128.22.998.998
Published: 2016
Journal Articles

Kte-C19 (anti-CD19 CAR T Cells) Induces Complete Remissions in Patients with Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Results from the Pivotal Phase 2 Zuma-1

Sattva S. Neelapu, MD, Frederick L. Locke, MD, Nancy L. Bartlett, MD, Lazaros Lekakis, MD, David Miklos, MD PhD, Caron A. Jacobson, MD, Ira Braunschweig, MD, Olalekan Oluwole, MBBS, MPH, Tanya Siddiqi, MD, Yi Lin, MD PhD, John Timmerman, MD, Patrick J. Stiff, Jonathan Friedberg, MD, Ian Flinn, Andre Goy, MD, Mitchell Smith, Abhinav Deol, MD, Umar Farooq, MD, Peter McSweeney, MD, Javier Munoz, MD, Irit Avivi, MD, Januario E. Castro, MD, Jason R. Westin, MD MS, Julio C. Chavez, MD, Armin Ghobadi, MD, Krishna V. Komanduri, MD, Ronald Levy, MD, Eric D. Jacobsen, Patrick Reagan, MD, Adrian Bot, MD PhD, John M. Rossi, MS, Lynn Navale, MS, Yizhou Jiang, PhD, Jeff S. Aycock, BA, Meg Elias, RN, BSN, Jeff Wiezorek, MD MS, William Y. Go, MD PhD
Journal: Blood
Blood (2016) 128 (22): LBA-6.
https://doi.org/10.1182/blood.V128.22.LBA-6.LBA-6
Published: 2016
Journal Articles

Phase 1 Clinical Results of the ZUMA-1 (KTE-C19-101) Study: A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of Anti-CD19 CAR T Cells (KTE-C19) in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

Frederick L. Locke, MD, Sattva S. Neelapu, MD, Nancy L Bartlett, MD, Tanya Siddiqi, MD, Julio C. Chavez, MD, Chitra M. Hosing, MD, Armin Ghobadi, MD, Lihua E. Budde, MD PhD, Lynn Navale, MS, Jeff S. Aycock, BA, Jeff Wiezorek, MD MS, William Y. Go, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3991.
https://doi.org/10.1182/blood.V126.23.3991.3991
Published: 2015